Literature DB >> 17949969

Testicular cancer: trends in mortality are well explained by changes in treatment and survival in the southern Netherlands since 1970.

R H A Verhoeven1, J W W Coebergh, L A L M Kiemeney, E L Koldewijn, S Houterman.   

Abstract

The aim of this study was to interpret changes in mortality from testicular cancer (TC) against the background of changes in treatment and survival in the south of The Netherlands. Five-year moving average standardised mortality rates were calculated. Primary treatment and relative survival were analysed according to histology, stage and year of diagnosis. The mortality rate dropped in the period 1979-1986 and then flattened out. The types of treatment that patients received did not change significantly over time and were according to the guidelines. Ten-year relative survival for seminoma TC patients improved from 81% (67-91%) in 1970-1979 to 95% (88-100%) in 2000-2002; for non-seminoma TC patients these rates were 54% (38-68%) and 92% (85-99%), respectively. Conditional 5-year relative survival for seminoma and non-seminoma TC patients 5 years after diagnosis was 99% and 96%, respectively. In conclusion, there was an enormous increase in relative survival and a significant decrease in mortality.

Entities:  

Mesh:

Year:  2007        PMID: 17949969     DOI: 10.1016/j.ejca.2007.08.022

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age.

Authors:  A Stang; L Jansen; B Trabert; C Rusner; A Eberle; A Katalinic; K Emrich; B Holleczek; H Brenner
Journal:  Cancer Epidemiol       Date:  2013-04-23       Impact factor: 2.984

2.  Benign neck metastasis of a testicular germ cell tumor.

Authors:  Haim Gavriel; Stephen Kleid
Journal:  Int Surg       Date:  2015-01

3.  GOLPH2 expression may serve as diagnostic marker in seminomas.

Authors:  Florian R Fritzsche; Glen Kristiansen; Marc-Oliver Riener; Manfred Dietel; Beibei Oelrich
Journal:  BMC Urol       Date:  2010-02-25       Impact factor: 2.264

4.  Platinum exposure and cause-specific mortality among patients with testicular cancer.

Authors:  Harmke J Groot; Flora E van Leeuwen; Sjoukje Lubberts; Simon Horenblas; Ronald de Wit; J Alfred Witjes; Gerard Groenewegen; Philip M Poortmans; Maarten C C M Hulshof; Otto W M Meijer; Igle J de Jong; Hetty A van den Berg; Tineke J Smilde; Ben G L Vanneste; Maureen J B Aarts; Katarzyna Jóźwiak; Alexandra W van den Belt-Dusebout; Jourik A Gietema; Michael Schaapveld
Journal:  Cancer       Date:  2019-11-15       Impact factor: 6.860

5.  A case of congenital single testis with testicular cancer patient and azoospermia who was able to collect spermatozoa with ipsilateral Onco-TESE.

Authors:  Kazumasa Hayashi; Teruo Inamoto; Haruhito Azuma; Hiroshi Masuda; Hirotsugu Oku
Journal:  Clin Case Rep       Date:  2020-11-23

6.  Late recurrence and second primary malignancy among 139 patients with germ cell tumors: long-term outcome of the disease in a single-center experience.

Authors:  Shunsuke Sato; Toshiaki Tanaka; Atsushi Takahashi; Masamichi Sasai; Hiroshi Kitamura; Naoya Masumori; Taiji Tsukamoto
Journal:  Jpn J Clin Oncol       Date:  2009-11-10       Impact factor: 3.019

Review 7.  The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?

Authors:  Margaret Ottaviano; Emilio Francesco Giunta; Pasquale Rescigno; Ricardo Pereira Mestre; Laura Marandino; Marianna Tortora; Vittorio Riccio; Sara Parola; Milena Casula; Panagiotis Paliogiannis; Antonio Cossu; Ursula Maria Vogl; Davide Bosso; Mario Rosanova; Brunello Mazzola; Bruno Daniele; Giuseppe Palmieri; Giovannella Palmieri
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

8.  Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.

Authors:  Lucia Nappi; Margaret Ottaviano; Pasquale Rescigno; Marianna Tortora; Giuseppe L Banna; Giulia Baciarello; Umberto Basso; Christina Canil; Alessia Cavo; Maria Cossu Rocca; Piotr Czaykowski; Ugo De Giorgi; Xavier Garcia Del Muro; Marilena Di Napoli; Giuseppe Fornarini; Jourik A Gietema; Daniel Y C Heng; Sebastien J Hotte; Christian Kollmannsberger; Marco Maruzzo; Carlo Messina; Franco Morelli; Sasja Mulder; Craig Nichols; Franco Nolè; Christoph Oing; Teodoro Sava; Simona Secondino; Giuseppe Simone; Denis Soulieres; Bruno Vincenzi; Paolo A Zucali; Sabino De Placido; Giovannella Palmieri
Journal:  Oncologist       Date:  2020-09-18       Impact factor: 5.837

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.